CSIMarket
 
Free Flow Usa Inc   (FFLO)
    Sector  Retail    Industry Automotive Aftermarket
   Industry Automotive Aftermarket
   Sector  Retail
 
Price: $0.2442 $0.00 0.000%
Day's High: $0.24420000612735748 Week Perf: 0.00
Day's Low: $ 0.24 30 Day Perf: -19.57 %
Volume (M): 0 52 Wk High: $ 0.41
Volume (M$): $ 0 52 Wk Avg: $0.10
Open: $0.24 52 Wk Low: $0.04



 Market Capitalization (Millions $) -
 Shares Outstanding (Millions) -
 Employees 3
 Revenues (TTM) (Millions $) 0
 Net Income (TTM) (Millions $) 0
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0

Business Description


Since the new management took over the company’s control on March 13, 2014, from S. Douglas Henderson, former CEO, it has remained focused in developing the solar energy business along with pharmaceutical (skin care product line), neither one of which has produced any revenues. However, the management continued its efforts to deploy “Solar Well” operation in India and Pakistan, due to economic instability no contract could be concluded.

Concurrent to the above efforts, a few prospects had shown keen interest in promotion of HYGIENiQ to the automotive industry. Approx.35% of the inventory was sold and paid for during the first quarter of 2016.

Upon taking over, the Company appointed Ferdinando (Fred) Ferrara as a Director and Sabir Saleem as CEO. There was no family relationship or other relationship between the Seller and the Purchaser.



   Company Address: 9243 John F. Kennedy Blvd. Suite 104 North Bergen 7047 NJ
   Company Phone Number: 789-3344   Stock Exchange / Ticker: FFLO


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
ADM   -2.84%    
• View Complete Report
   



Announcement

Free Flow, Inc. Moves into Pharmaceuticals with $10 Million Acquisition Agreement

Published Mon, Aug 26 2024 12:34 PM UTC

Free Flow, Inc. (FFLO) has announced a significant step toward diversifying its business portfolio with an initial agreement to acquire a pharmaceutical company, marking a strategic expansion into the healthcare sector. The targeted acquisition, valued at approximately $10 million, is poised to enhance FFLO’s market presence and is expected to generate projected gross rev...




Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) -
Price to Sales (Expected) -
Price to Book -
PEG (TTM) -

Financial Strength Current
Quick Ratio 0.02
Working Capital Ratio 1.04
Leverage Ratio (MRQ) -
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -0.01 $
Revenues (TTM) -
Cash Flow (TTM) -
Cash -
Book Value -
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 13,967
Net Income per Employee (TTM) -68,143
Receivable Turnover Ratio (TTM) -
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) 0.13

Profitability Ratios Current
Gross Margin (MRQ) 0 %
Operating Margin (MRQ) -457.26 %
Net Margin (MRQ) -457.26 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -



Free Flow Usa Inc's Segments





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.